Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Kidney Dis. 2014 Jul;64(1):104-10. doi: 10.1053/j.ajkd.2013.11.018. Epub 2014 Jan 3.

Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients.

Author information

  • 1Nephrology and Hypertension, Mayo Clinic, Rochester, MN. Electronic address: hickson.latonya@mayo.edu.
  • 2Internal Medicine, Mayo Clinic, Rochester, MN.
  • 3Hospital Internal Medicine, Mayo Clinic, Rochester, MN.
  • 4Infectious Diseases, Mayo Clinic, Rochester, MN; Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • 5Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • 6Infectious Diseases, Mayo Clinic, Rochester, MN.

Abstract

BACKGROUND:

Infection is a serious complication of cardiovascular implantable electronic device (CIED) implantation. Kidney failure is as an independent risk factor for CIED infection and associated mortality. The presence of multiple comorbid conditions may contribute to varied clinical presentations and poor outcomes in hemodialysis (HD)-dependent patients with cardiac device infection.

STUDY DESIGN:

Case series.

SETTING & PARTICIPANTS:

CIED infections in HD patients (n=17) and non-HD patients (n=398) at Mayo Clinic in Rochester, MN, between 1991 and 2008.

OUTCOMES:

Surgical management and death.

MEASUREMENTS:

Clinical presentations, microbial organisms.

RESULTS:

Of 415 patients admitted with CIED infection, 17 (4%) were receiving maintenance HD therapy. Among those on HD therapy, mean age was 72±15 (SD) years, 59% were women, and 53% had a central venous catheter for dialysis access. All 17 patients receiving HD therapy presented with CIED-associated bloodstream infection and 41% of these had infected vegetations on CIED leads or cardiac valves. A majority (82%) were managed with complete device removal and almost half (43%) received a replacement device when bloodstream infection cleared. Device infection was associated with significant short-term mortality in HD patients and 90-day survival was only 76% in this group of patients.

LIMITATIONS:

Smaller sample size, majority white cohort, observational study.

CONCLUSIONS:

CIED infection in patients receiving HD usually is associated with bloodstream infection and frequently is complicated with device-related endocarditis. Despite complete device removal in the majority of HD patients with infection, mortality remains high.

Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

KEYWORDS:

Bacteremia; bloodstream infection; cardiovascular implantable electronic device (CIED); defibrillator; end-stage renal disease (ESRD); hemodialysis; mortality; pacemaker

PMID:
24388672
[PubMed - indexed for MEDLINE]
PMCID:
PMC4069232
[Available on 2015/7/1]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk